{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:59:06Z","timestamp":1788994746481,"version":"build-2803163510"},"reference-count":9,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:00:00Z","timestamp":1716595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1111\/jdv.20017","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T21:19:16Z","timestamp":1716671956000},"page":"995-996","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["<scp>TNF<\/scp> inhibitors and cardiovascular risk: Friend or foe?"],"prefix":"10.1111","volume":"38","author":[{"given":"Joel M.","family":"Gelfand","sequence":"first","affiliation":[{"name":"Department of Dermatology and Department of Biostatistics, Epidemiology, and Informatics Center for Clinical Sciences in Dermatology University of Pennsylvania Perelman School of Medicine  Philadelphia Pennsylvania USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6649-3755","authenticated-orcid":false,"given":"Michael","family":"Garshick","sequence":"additional","affiliation":[{"name":"Leon H. Charney Division of Cardiology, Department of Medicine NYU Grossman School of Medicine  New York New York USA"},{"name":"Ronald O. Perelman Department of Dermatology NYU Grossman School of Medicine  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,5,25]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand JM","year":"2006","journal-title":"JAMA"},{"key":"e_1_2_5_3_1","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy SM","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_5_4_1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low\u2010dose colchicine for secondary prevention of coronary artery disease: JACC review topic of the week","volume":"82","author":"Nelson K","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_5_5_1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007394","article-title":"Effect of 2 psoriasis treatments on vascular inflammation and novel inflammatory cardiovascular biomarkers: a randomized placebo\u2010controlled trial","volume":"11","author":"Mehta NN","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"e_1_2_5_6_1","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/01.CIR.99.25.3213","article-title":"TNF\u2010alpha and heart failure. The difference between proof of principle and hypothesis testing","volume":"99","author":"Francis GS","year":"1999","journal-title":"Circulation"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.09.033"},{"key":"e_1_2_5_8_1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2013.01.011","article-title":"Major cardiovascular events associated with anti\u2010IL 12\/23 agents: a tale of two meta\u2010analyses","volume":"68","author":"Dommasch ED","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_5_9_1","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/jdv.19900","article-title":"Reducing cardiovascular risk in immune\u2010mediated inflammatory diseases: tumour necrosis factor inhibitors compared to conventional therapies\u2010a systematic review and meta\u2010analysis","volume":"38","author":"Galajda N","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_5_10_1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low\u2010dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker PM","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.20017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T21:22:12Z","timestamp":1716672132000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.20017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1111\/jdv.20017"],"URL":"https:\/\/doi.org\/10.1111\/jdv.20017","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,25]]},"assertion":[{"value":"2024-03-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}